Archives of Clinical Infectious Diseases

Published by: Kowsar

Sero - Epidemiology of Hepatitis E and D Infections among HIV - Infected and HIV/HCV - Coinfected Patients in Jahrom, Southern Iran

Enayatollah Shadmand 1 , Rasoul Baharlou 1 , Mohammad Reza Shokouh 1 , Seyed Dawood Mousavi Nasab 2 , Abbas Ahmadi Vasmehjani 3 , Kaveh Sadeghi 3 , * and Nayeb Ali Ahmadi 4
Authors Information
1 Department of Microbiology and Immunology, Jahrom University of Medical Sciences, Jahrom, Iran
2 Departments of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran
3 Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2018, 13 (2); e77069
  • Published Online: April 28, 2018
  • Article Type: Research Article
  • Received: August 27, 2016
  • Revised: March 5, 2017
  • Accepted: March 14, 2017
  • DOI: 10.5812/archcid.77069

To Cite: Shadmand E, Baharlou R, Shokouh M R, Mousavi Nasab S D, Ahmadi Vasmehjani A, et al. Sero - Epidemiology of Hepatitis E and D Infections among HIV - Infected and HIV/HCV - Coinfected Patients in Jahrom, Southern Iran, Arch Clin Infect Dis. 2018 ; 13(2):e77069. doi: 10.5812/archcid.77069.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23-31. doi: 10.1159/000149370. [PubMed: 6409836].
  • 2. Goens SD, Perdue ML. Hepatitis E viruses in humans and animals. Anim Health Res Rev. 2004;5(2):145-56. [PubMed: 15984321].
  • 3. Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, et al. Hepatitis E: An emerging infection in high income countries. J Clin Virol. 2014;59(2):81-8. doi: 10.1016/j.jcv.2013.11.013. [PubMed: 24388207].
  • 4. Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol. 1996;25(1):20-7. [PubMed: 8836897].
  • 5. Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol. 2006;307:151-71. [PubMed: 16903225].
  • 6. Delic D, Gotic M, Ostric V, Fridman V, Nikolic P, Jemuovic L, et al. Epidemiology of hepatitis D virus (delta) infection in Yugoslavia. Liver. 1993;13(6):302-4. [PubMed: 8295493].
  • 7. Ashrafi Hafez A, Baharlou R, Mousavi Nasab SD, Ahmadi Vasmehjani A, Shayestehpour M, Joharinia N, et al. Molecular epidemiology of different hepatitis C genotypes in serum and peripheral blood mononuclear cells in jahrom city of iran. Hepat Mon. 2014;14(5). e16391. doi: 10.5812/hepatmon.16391. [PubMed: 24976833]. [PubMed Central: PMC4071316].
  • 8. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136(5):1629-38. doi: 10.1053/j.gastro.2009.01.052. [PubMed: 19208358].
  • 9. Behzadpour D, Ahmadi Vasmehjani A, Mousavi Nasab SD, Ahmadi NA, Baharlou R. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes. Pathog Glob Health. 2016;110(7-8):310-5. doi: 10.1080/20477724.2016.1253532. [PubMed: 27830997]. [PubMed Central: PMC5189870].
  • 10. Mousavi Nasab SD, Baharlou R, Piroozmand A, Toghyani H, Shadmand E, Fazel H, et al. Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city. Gastroenterol Hepatol Bed Bench. 2015;8(4):278-87. [PubMed: 26468348]. [PubMed Central: PMC4600518].
  • 11. Ottobrelli A, Marzano A, Smedile A, Recchia S, Salizzoni M, Cornu C, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology. 1991;101(6):1649-55. [PubMed: 1955130].
  • 12. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat. 2014;21(2):78-89. doi: 10.1111/jvh.12156. [PubMed: 24383921].
  • 13. Sotoodeh Jahromi A, Ahmadi-Vasmehjani A, Zabetian H, Hakimelahi H, Yusefi A, Sanie MS, et al. Sero-Epidemiological Study of Hepatitis E Virus among Thalassemia as High Risk Patients: A Cross-Sectional Survey in Jahrom, Southern, Iran. Glob J Health Sci. 2016;8(9):53885. doi: 10.5539/gjhs.v8n9p245. [PubMed: 27157168]. [PubMed Central: PMC5064080 publication of this paper].
  • 14. De Silva S, Hassan-Ibrahim MO, Austin M, Newport M, Verma S. Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis. 2012;44(11):930-4. doi: 10.1016/j.dld.2012.04.011. [PubMed: 22592074].
  • 15. Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387-94. doi: 10.1016/j.jhep.2006.09.016. [PubMed: 17125878].
  • 16. Rivero-Juarez A, Camacho A, Merchante N, Perez-Camacho I, Macias J, Ortiz-Garcia C, et al. Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV. PLoS One. 2013;8(7). e68953. doi: 10.1371/journal.pone.0068953. [PubMed: 23874824]. [PubMed Central: PMC3715524].
  • 17. Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, et al. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect. 2013;66(1):103-6. doi: 10.1016/j.jinf.2011.11.027. [PubMed: 22166370].
  • 18. Novick DM, Farci P, Croxson TS, Taylor MB, Schneebaum CW, Lai ME, et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis. 1988;158(4):795-803. [PubMed: 3171227].
  • 19. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology. 1992;15(4):578-83. [PubMed: 1551633].
  • 20. Arribas JR, Gonzalez-Garcia JJ, Lorenzo A, Montero D, Ladron de Guevara C, Montes M, et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS. 2005;19(13):1361-5. [PubMed: 16103766].
  • 21. Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, Foroughi M, et al. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis. Hepat Mon. 2013;13(5). e7481. doi: 10.5812/hepatmon.7481. [PubMed: 23914228]. [PubMed Central: PMC3728973].
  • 22. Naeimi B, Mazloom Kalimani F, Pourfatolah AA, Azimzadeh M, Mankhian A, Akbarzadeh S, et al. Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran. Hepat Mon. 2015;15(11). e29219. doi: 10.5812/hepatmon.29219. [PubMed: 26834784]. [PubMed Central: PMC4719130].
  • 23. Ingiliz P, Mayr C, Obermeier M, Herbst H, Polywka S, Pischke S. Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clin Res Hepatol Gastroenterol. 2016;40(3):e23-5. doi: 10.1016/j.clinre.2016.01.005. [PubMed: 27055386].
  • 24. Gu XH, Chen Z, Dai RY, Zhang ML, Tang HM, Chen LB, et al. Analysis on the clinical features of 507 HDV-infected patients. Cell Biochem Biophys. 2014;70(3):1829-32. doi: 10.1007/s12013-014-0137-8. [PubMed: 25085619].
  • 25. Gisa A, Suneetha PV, Behrendt P, Pischke S, Bremer B, Falk CS, et al. Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection. J Viral Hepat. 2016;23(4):305-15. doi: 10.1111/jvh.12495. [PubMed: 26852892].
  • 26. Jardi R, Crespo M, Homs M, van den Eynde E, Girones R, Rodriguez-Manzano J, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med. 2012;13(6):379-83. doi: 10.1111/j.1468-1293.2011.00985.x. [PubMed: 22257075].
  • 27. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 2012;13(1):83-8. doi: 10.1111/j.1468-1293.2011.00942.x. [PubMed: 21819531].
  • 28. Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat. 2009;16(12):895-6. doi: 10.1111/j.1365-2893.2009.01138.x. [PubMed: 19413691].
  • 29. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698-709. doi: 10.1016/S1473-3099(08)70255-X. [PubMed: 18992406].
  • 30. Acharya SK, Panda SK. Hepatitis E virus: epidemiology, diagnosis, pathology and prevention. Trop Gastroenterol. 2006;27(2):63-8. [PubMed: 17089614].
  • 31. Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, et al. Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol. 2005;14(4):329-35. [PubMed: 16400347].
  • 32. Saravanan S, Madhavan V, Velu V, Murugavel KG, Waldrop G, Solomon SS, et al. High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region. J Int Assoc Provid AIDS Care. 2014;13(1):85-90. doi: 10.1177/2325957413488166. [PubMed: 23722085]. [PubMed Central: PMC4114572].
  • 33. Ramezani A, Velayati AA, Khorami-Sarvestani S, Eslamifar A, Mohraz M, Banifazl M, et al. Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran. Int J STD AIDS. 2013;24(10):769-74. doi: 10.1177/0956462413484457. [PubMed: 23970597].
  • 34. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367(13):1237-44. doi: 10.1056/NEJMra1204512. [PubMed: 23013075].
  • 35. Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis. 2013;57(3):465-8. doi: 10.1093/cid/cit224. [PubMed: 23575198].
  • 36. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol. 2002;40(8):3047-9. [PubMed: 12149376]. [PubMed Central: PMC120675].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments